Skip to main content
Top
Published in: Rheumatology International 11/2016

01-11-2016 | Health Services Research

Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain

Authors: R. Lopez-Gonzalez, D. Seoane-Mato, S. Perez-Vicente, M. A. Martin-Martinez, F. Sanchez-Alonso, L. Silva-Fernandez, On behalf of the emAR II Study Group

Published in: Rheumatology International | Issue 11/2016

Login to get access

Abstract

The aim of this work was to assess the variability in the use of health-care resources, based on the number of visits to rheumatology departments by rheumatoid arthritis patients, in Spain, and its association with patient, physician and center characteristics. The sample consisted of patient records of men and women (aged 16 or older), with a clinical diagnosis of RA, who met the American Rheumatism Association 1987 revised criteria and who had been treated in a rheumatology department at a Spanish hospital with at least one visit to a rheumatologist during the two years preceding the date of the study. To analyze which variables were independently associated with the number of consultations, those with a statistically significant result in the bivariate analysis, or which were clinically relevant or deemed confounders, were used in the construction of a linear regression model. The records of 1188 RA patients were studied. The linear regression model explained the 26.67 % of the variability in the number of visits. The number of csDMARDs prescribed, the administration of biological therapy, corticoid prescription, the presence of nursing consultation, mean time to first visit in the department and attended population showed a positive significant association, while the presence of telephone consultation, distance from the hospital to the patient´s residence (≥20 km) and drug monitoring by rheumatology department + primary care physician or by other specialists were negatively associated with the number of consultations. We observed a high variability in the number of visits, which remains partially unexplained even after taking into account individual, physician and center characteristics.
Literature
1.
go back to reference Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41(1):88–95CrossRef Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41(1):88–95CrossRef
2.
go back to reference Puolakka K, Kautiainen H, Pekurinen M, Möttönen T, Hannonen P, Korpela M, FIN-RACo Trial Group et al (2006) Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 65(7):899–904CrossRefPubMed Puolakka K, Kautiainen H, Pekurinen M, Möttönen T, Hannonen P, Korpela M, FIN-RACo Trial Group et al (2006) Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 65(7):899–904CrossRefPubMed
3.
go back to reference Burton WN, Chen CY, Schultz AB, Conti DJ, Pransky G, Edington DW (2006) Worker productivity loss associated with arthritis. Dis Manag 9(3):131–143CrossRefPubMed Burton WN, Chen CY, Schultz AB, Conti DJ, Pransky G, Edington DW (2006) Worker productivity loss associated with arthritis. Dis Manag 9(3):131–143CrossRefPubMed
4.
go back to reference Yelin E, Trupin L, Wong B, Rush S (2002) The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. J Rheumatol 29(9):1851–1857PubMed Yelin E, Trupin L, Wong B, Rush S (2002) The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. J Rheumatol 29(9):1851–1857PubMed
5.
go back to reference Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L (2014) Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 73(3):510–515CrossRefPubMedPubMedCentral Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L (2014) Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 73(3):510–515CrossRefPubMedPubMedCentral
6.
go back to reference Jacobs JW (2012) Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 4):iv3–iv8 Jacobs JW (2012) Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 4):iv3–iv8
7.
go back to reference Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de Estudio de Costes, Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain. Reumatol Clin 1(3):142–149CrossRefPubMed Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de Estudio de Costes, Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain. Reumatol Clin 1(3):142–149CrossRefPubMed
8.
go back to reference van den Hout WB, Bremander A, Vliet Vlieland TP (2011) Recommendations for economic evaluations of non-pharmacological arthritis care: results from the CARE VI meeting 2010. Musculoskelet Care 9(2):120–123CrossRef van den Hout WB, Bremander A, Vliet Vlieland TP (2011) Recommendations for economic evaluations of non-pharmacological arthritis care: results from the CARE VI meeting 2010. Musculoskelet Care 9(2):120–123CrossRef
9.
go back to reference Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de estudio de Costes y Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain. Reumatol Clin 1(4):193–199CrossRefPubMed Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de estudio de Costes y Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain. Reumatol Clin 1(4):193–199CrossRefPubMed
10.
go back to reference Schoels M, Wong J, Scott DL, Zink A, Richards P, Landewé R et al (2010) Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69(6):995–1003CrossRefPubMed Schoels M, Wong J, Scott DL, Zink A, Richards P, Landewé R et al (2010) Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69(6):995–1003CrossRefPubMed
11.
go back to reference Corallo AN, Croxford R, Goodman DC, Bryan EL, Srivastava D, Stukel TA (2014) A systematic review of medical practice variation in OECD countries. Health Policy 114(1):5–14CrossRefPubMed Corallo AN, Croxford R, Goodman DC, Bryan EL, Srivastava D, Stukel TA (2014) A systematic review of medical practice variation in OECD countries. Health Policy 114(1):5–14CrossRefPubMed
12.
go back to reference González-Alvaro I, Hernández-García C, Villaverde García E, Vargas E, Ortiz AM (2002) Variations in the drug treatment of rheumatoid arthritis in Spain. Med Clin 118(20):771–776CrossRef González-Alvaro I, Hernández-García C, Villaverde García E, Vargas E, Ortiz AM (2002) Variations in the drug treatment of rheumatoid arthritis in Spain. Med Clin 118(20):771–776CrossRef
13.
go back to reference Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, Pato E, Fernandez-Gutierrez B, Jover JA, Loza E, emAR Study Group (2008) Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain. Scand J Rheumatol 37(6):419–426CrossRefPubMed Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, Pato E, Fernandez-Gutierrez B, Jover JA, Loza E, emAR Study Group (2008) Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain. Scand J Rheumatol 37(6):419–426CrossRefPubMed
14.
go back to reference Silva-Fernández L, Pérez-Vicente S, Martín-Martínez MA, López-González R, on behalf of the emAR II Study Group (2015) Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain. Semin Arthritis Rheum 44(6):633–640CrossRefPubMed Silva-Fernández L, Pérez-Vicente S, Martín-Martínez MA, López-González R, on behalf of the emAR II Study Group (2015) Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain. Semin Arthritis Rheum 44(6):633–640CrossRefPubMed
15.
go back to reference Rosales-Alexander JL, Balsalobre Aznar J, Pérez-Vicente S, Magro-Checa C (2015) Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study. Rheumatology (Oxford) 54(8):1459–1463CrossRef Rosales-Alexander JL, Balsalobre Aznar J, Pérez-Vicente S, Magro-Checa C (2015) Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study. Rheumatology (Oxford) 54(8):1459–1463CrossRef
16.
go back to reference Loza E, Abasolo L, Clemente D, Lopez-Gonzalez R, Rodriguez L, Vadillo C et al (2007) Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain. J Rheumatol 34:1485–1490PubMed Loza E, Abasolo L, Clemente D, Lopez-Gonzalez R, Rodriguez L, Vadillo C et al (2007) Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain. J Rheumatol 34:1485–1490PubMed
17.
go back to reference Maese J, García De Yébenes MJ, Carmona L, Hernández-García C, el Grupo de Estudio emAR II (2012) Management of rheumatoid arthritis in Spain emAR II. Clinical characteristics of the patients. Reumatol Clin 8(5):236–242CrossRefPubMed Maese J, García De Yébenes MJ, Carmona L, Hernández-García C, el Grupo de Estudio emAR II (2012) Management of rheumatoid arthritis in Spain emAR II. Clinical characteristics of the patients. Reumatol Clin 8(5):236–242CrossRefPubMed
18.
go back to reference Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48CrossRefPubMed Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48CrossRefPubMed
19.
go back to reference Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10):2220–2230CrossRefPubMed Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10):2220–2230CrossRefPubMed
20.
go back to reference Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35(5):498–502CrossRefPubMed Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35(5):498–502CrossRefPubMed
21.
go back to reference Standfield L, Norris S, Harvey C, Elliot L, Riordan J, Hall S, Day R, Nash P, Thirunavukkarasu K, Robertson J, Palmer T (2010) Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: a cross-sectional, multicenter study. Clin Ther 32(7):1329–1342CrossRefPubMed Standfield L, Norris S, Harvey C, Elliot L, Riordan J, Hall S, Day R, Nash P, Thirunavukkarasu K, Robertson J, Palmer T (2010) Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: a cross-sectional, multicenter study. Clin Ther 32(7):1329–1342CrossRefPubMed
22.
go back to reference Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A et al (2006) Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33:86–90PubMed Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A et al (2006) Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33:86–90PubMed
23.
go back to reference Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis C (2001) Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 28:2201–2208PubMed Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis C (2001) Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 28:2201–2208PubMed
24.
go back to reference Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, Bird H, Hill J (2014) The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Ann Rheum Dis 73(11):1975–1982CrossRefPubMed Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, Bird H, Hill J (2014) The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Ann Rheum Dis 73(11):1975–1982CrossRefPubMed
25.
go back to reference Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA (2013) Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritis. Ann Rheum Dis 72(6):836–843CrossRefPubMed Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA (2013) Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritis. Ann Rheum Dis 72(6):836–843CrossRefPubMed
26.
go back to reference Primdahl J, Sørensen J, Horn HC, Petersen R, Hørslev-Petersen K (2014) Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity–patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis 73(2):357–364CrossRefPubMed Primdahl J, Sørensen J, Horn HC, Petersen R, Hørslev-Petersen K (2014) Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity–patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis 73(2):357–364CrossRefPubMed
27.
go back to reference van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH (2015) Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis 74(5):806–812CrossRefPubMed van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH (2015) Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis 74(5):806–812CrossRefPubMed
28.
go back to reference van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861–870CrossRefPubMed van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861–870CrossRefPubMed
29.
go back to reference Birnbaum HG, Pike C, Banerjee R, Waldman T, Cifaldi M (2012) Changes in utilization and costs for patients with rheumatoid arthritis, 1997–2006. Pharmacoeconomics 30(4):323–336CrossRefPubMed Birnbaum HG, Pike C, Banerjee R, Waldman T, Cifaldi M (2012) Changes in utilization and costs for patients with rheumatoid arthritis, 1997–2006. Pharmacoeconomics 30(4):323–336CrossRefPubMed
30.
go back to reference Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM (2005) When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ 173(11):1335–1340CrossRefPubMedPubMedCentral Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM (2005) When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ 173(11):1335–1340CrossRefPubMedPubMedCentral
31.
go back to reference Põlluste K, Kallikorm R, Meiesaar K, Lember M (2012) Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 29(4):433–440CrossRefPubMed Põlluste K, Kallikorm R, Meiesaar K, Lember M (2012) Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 29(4):433–440CrossRefPubMed
32.
go back to reference Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, Curtis BS (2010) Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm 16(8):593–604PubMed Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, Curtis BS (2010) Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm 16(8):593–604PubMed
33.
go back to reference Pincus T, Yazici Y, Sokka T (2007) Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 21:601–628CrossRefPubMed Pincus T, Yazici Y, Sokka T (2007) Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 21:601–628CrossRefPubMed
Metadata
Title
Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain
Authors
R. Lopez-Gonzalez
D. Seoane-Mato
S. Perez-Vicente
M. A. Martin-Martinez
F. Sanchez-Alonso
L. Silva-Fernandez
On behalf of the emAR II Study Group
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3547-7

Other articles of this Issue 11/2016

Rheumatology International 11/2016 Go to the issue